The tissue micro-array as a translational research tool for biomarker profiling and validationSELIGSON, David B.Biomarkers (London. Print). 2005, Vol 10, pp S77-S82, issn 1354-750X, SUP1Article

Prognostic relevance of the mTOR pathway in renal cell carcinoma : Implications for molecular patient selection for targeted therapyPANTUCK, Allan J; SELIGSON, David B; KLATTE, Tobias et al.Cancer. 2007, Vol 109, Num 11, pp 2257-2267, issn 0008-543X, 11 p.Article

Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcomeWADEHRA, Madhuri; NATARAJAN, Sathima; SELIGSON, David B et al.Cancer. 2006, Vol 107, Num 1, pp 90-98, issn 0008-543X, 9 p.Article

Absent CD44v6 Expression is an Independent Predictor of Poor Urothelial Bladder Cancer OutcomeKLATTE, Tobias; SELIGSON, David B; JIAN YU RAO et al.The Journal of urology. 2010, Vol 183, Num 6, pp 2403-2408, issn 0022-5347, 6 p.Article

Molecular Signatures of Localized Clear Cell Renal Cell Carcinoma to Predict Disease-Free Survival after NephrectomyKLATTE, Tobias; SELIGSON, David B; LAROCHELLE, Jeffrey et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 3, pp 894-900, issn 1055-9965, 7 p.Article

The Chemokine Receptor CXCR3 is an Independent Prognostic Factor in Patients With Localized Clear Cell Renal Cell CarcinomaKLATTE, Tobias; SELIGSON, David B; LEPPERT, John T et al.The Journal of urology. 2008, Vol 179, Num 1, pp 61-66, issn 0022-5347, 6 p.Article

Tissue microarrays in the study of non-neoplastic disease of the nervous systemGOLDSTINE, Jared; SELIGSON, David B; BEIZAI, Pouneh et al.Journal of neuropathology and experimental neurology. 2002, Vol 61, Num 8, pp 653-662, issn 0022-3069Article

Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2αKROEGER, Nils; SELIGSON, David B; SIGNORETTI, Sabina et al.European journal of cancer (1990). 2014, Vol 50, Num 8, pp 1531-1540, issn 0959-8049, 10 p.Article

Carbonic Anhydrase IX in Bladder Cancer : A Diagnostic, Prognostic, and Therapeutic Molecular MarkerKLATTE, Tobias; SELIGSON, David B; JIAN YU RAO et al.Cancer. 2009, Vol 115, Num 7, pp 1448-1458, issn 0008-543X, 11 p.Article

Global histone modification patterns predict risk of prostate cancer recurrenceSELIGSON, David B; HORVATH, Steve; TAO SHI et al.Nature (London). 2005, Vol 435, Num 7046, pp 1262-1266, issn 0028-0836, 5 p.Article

Epithelial cell adhesion molecule (KSA) expression: Pathobiology and its role as an independent predictor of survival in renal cell carcinomaSELIGSON, David B; PANTUCK, Allan J; BELLDEGRUN, Arie S et al.Clinical cancer research. 2004, Vol 10, Num 8, pp 2659-2669, issn 1078-0432, 11 p.Article

Analysis of the Na, K-ATPase α- and β-subunit expression profiles of bladder cancer using tissue microarraysESPINEDA, Cromwell; SELIGSON, David B; BALL, William James et al.Cancer. 2003, Vol 97, Num 8, pp 1859-1868, issn 0008-543X, 10 p.Article

Smoking Negatively Impacts Renal Cell Carcinoma Overall and Cancer-Specific SurvivalKROEGER, Nils; KLATTE, Tobias; BIRKHAUSER, Frédéric D et al.Cancer. 2012, Vol 118, Num 7, pp 1795-1802, issn 0008-543X, 8 p.Article

Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704MANUYAKORN, Ananya; PAULUS, Rebecca; KURDISTANI, Siavash K et al.Journal of clinical oncology. 2010, Vol 28, Num 8, pp 1358-1365, issn 0732-183X, 8 p.Article

CA9 Gene: Single Nucleotide Polymorphism Predicts Metastatic Renal Cell Carcinoma PrognosisDE MARTINO, Michela; KLATTE, Tobias; SELIGSON, David B et al.The Journal of urology. 2009, Vol 182, Num 2, pp 728-734, issn 0022-5347, 7 p.Article

Global Levels of Histone Modifications Predict Prognosis in Different CancersSELIGSON, David B; HORVATH, Steve; MCBRIAN, Matthew A et al.The American journal of pathology. 2009, Vol 174, Num 5, pp 1619-1628, issn 0002-9440, 10 p.Article

Hypoxia-lnducible Factor 1α in Clear Cell Renal Cell CarcinomaKLATTE, Tobias; SELIGSON, David B; RIGGS, Stephen B et al.Clinical cancer research. 2007, Vol 13, Num 24, pp 7388-7393, issn 1078-0432, 6 p.Article

Clinical, Molecular, and Genetic Correlates of Lymphatic Spread in Clear Cell Renal Cell CarcinomaKROEGER, Nils; SELIGSON, David B; PANTUCK, Allan J et al.European urology. 2012, Vol 61, Num 5, pp 888-895, issn 0302-2838, 8 p.Article

Pathological, Immunohistochemical and Cytogenetic Features of Papillary Renal Cell Carcinoma With Clear Cell FeaturesKLATTE, Tobias; SAID, Jonathan W; SELIGSON, David B et al.The Journal of urology. 2011, Vol 185, Num 1, pp 30-35, issn 0022-5347, 6 p.Article

Epithelial Membrane Protein-2 Expression Is an Early Predictor of Endometrial Cancer DevelopmentHABEEB, Omar; GOODGLICK, Lee; SOSLOW, Robert A et al.Cancer. 2010, Vol 116, Num 20, pp 4718-4726, issn 0008-543X, 9 p.Article

Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason scoreLAM, John S; SELIGSON, David B; HONG YU et al.BJU international (Papier). 2006, Vol 98, Num 2, pp 445-451, issn 1464-4096, 7 p.Article

Cytogenetic and Molecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell CarcinomaKLATTE, Tobias; PANTUCK, Allan J; SAID, Jonathan W et al.Clinical cancer research (Print). 2009, Vol 15, Num 4, pp 1162-1169, issn 1078-0432, 8 p.Article

Development of a Real-time RT-PCR Assay for Detecting EGFRvlll in Glioblastoma SamplesYOSHIMOTO, Koji; JULIE DANG; WINTHER, Henrik et al.Clinical cancer research. 2008, Vol 14, Num 2, pp 488-493, issn 1078-0432, 6 p.Article

Expression of arginase II in prostate cancerMUMENTHALER, Shannon M; HONG YU; TZE, Sheila et al.International journal of oncology. 2008, Vol 32, Num 2, pp 357-365, issn 1019-6439, 9 p.Article

Na,K-Adenosine Triphosphatase α₁-Subunit Predicts Survival of Renal Clear Cell CarcinomaSELIGSON, David B; RAJASEKARAN, Sigrid A; HONG YU et al.The Journal of urology. 2008, Vol 179, Num 1, pp 338-345, issn 0022-5347, 8 p.Article